NasdaqCM - Delayed Quote USD
Cassava Sciences, Inc. (SAVA)
2.2400
+0.1700
+(8.21%)
At close: May 20 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | -0.55 | 0 |
| Low Estimate | 0 | 0 | -0.55 | 0 |
| High Estimate | 0 | 0 | -0.55 | 0 |
| Year Ago EPS | -- | -1.28 | -2.86 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.46 | -0.4 | -0.88 | -0.68 |
| EPS Actual | -0.43 | -1.28 | -0.58 | -0.57 |
| Difference | 0.03 | -0.88 | 0.3 | 0.11 |
| Surprise % | 6.52% | -219.25% | 34.09% | 16.18% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.55 | 0 |
| 7 Days Ago | 0 | 0 | -0.55 | 0 |
| 30 Days Ago | 0 | 0 | -0.62 | 0 |
| 60 Days Ago | 0 | 0 | -1.21 | 0 |
| 90 Days Ago | 0 | 0 | -1.21 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SAVA | -- | -- | 80.77% | -- |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/25/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/4/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 11/26/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/8/2024 |
| Upgrade | HC Wainwright & Co.: Neutral to Buy | 10/8/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 8/13/2024 |
Related Tickers
CABA Cabaletta Bio, Inc.
1.8800
-2.08%
AVXL Anavex Life Sciences Corp.
7.53
-10.78%
EYEN Eyenovia, Inc.
1.6700
+47.79%
ANVS Annovis Bio, Inc.
2.1400
+0.94%
AFMD Affimed N.V.
0.1815
0.00%
BLUE bluebird bio, Inc.
4.9800
0.00%
TNXP Tonix Pharmaceuticals Holding Corp.
29.90
+12.41%
NVAX Novavax, Inc.
7.68
-0.78%
PTIX Protagenic Therapeutics, Inc.
6.88
-38.02%
NCNA NuCana plc
0.0464
-3.73%